gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study
The association between impaired spermatogenesis and TGCT has stimulated research on shared genetic factors. Y chromosome-linked partial AZFc deletions predispose to oligozoospermia and were also studied in TGCT patients with controversial results. In the largest study reporting the association betw...
Gespeichert in:
Veröffentlicht in: | European journal of human genetics : EJHG 2019-10, Vol.27 (10), p.1578-1588 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1588 |
---|---|
container_issue | 10 |
container_start_page | 1578 |
container_title | European journal of human genetics : EJHG |
container_volume | 27 |
creator | Moreno-Mendoza, Daniel Casamonti, Elena Paoli, Donatella Chianese, Chiara Riera-Escamilla, Antoni Giachini, Claudia Fino, Maria Grazia Cioppi, Francesca Lotti, Francesco Vinci, Serena Magini, Angela Ars, Elisabet Sanchez-Curbelo, Josvany Ruiz-Castane, Eduard Lenzi, Andrea Lombardo, Francesco Krausz, Csilla |
description | The association between impaired spermatogenesis and TGCT has stimulated research on shared genetic factors. Y chromosome-linked partial AZFc deletions predispose to oligozoospermia and were also studied in TGCT patients with controversial results. In the largest study reporting the association between gr/gr deletion and TGCT, sperm parameters were unknown. Hence, it remains to be established whether this genetic defect truly represents a common genetic link between TGCT and impaired sperm production. Our aim was to explore the role of the following Y chromosome-linked factors in the predisposition to TGCT: (i) gr/gr deletion in subjects with known sperm parameters; (ii) other partial AZFc deletions and, for the first time, the role of partial AZFc duplications; (iii) DAZ gene dosage variation. 497 TGCT patients and 2030 controls from two Mediterranean populations with full semen/andrological characterization were analyzed through a series of molecular genetic techniques. Our most interesting finding concerns the gr/gr deletion and DAZ gene dosage variation (i.e., DAZ copy number is different from the reference sequence), both conferring TGCT susceptibility. In particular, the highest risk was observed when normozoospermic TGCT and normozoospermic controls were compared (OR = 3.7; 95% CI = 1.5-9.1; p = 0.006 for gr/gr deletion and OR = 1.8; 95% CI = 1.1-3.0; p = 0.013 for DAZ gene dosage alteration). We report in the largest European study population the predisposing effect of gr/gr deletion to TGCT as an independent risk factor from impaired spermatogenesis. Our finding implies regular tumour screening/follow-up in male family members of TGCT patients with gr/gr deletion and in infertile gr/gr deletion carriers. |
doi_str_mv | 10.1038/s41431-019-0420-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6777534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2288674874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-b38307788a851fceb06e60ec57887f590aac70814aab2e5e1e97ef264d2c52e3</originalsourceid><addsrcrecordid>eNpVkctKxTAQhoMo3h_AjQRcV5Mm7eS4EES8geDGfchJp7WSNjVJhfMQvrM5HBXdZELmny8z8xNywtk5Z0JdRMml4AXji4LJkhWwRfa5hLqopFDb-c64KqTiYo8cxPjGWE4C3yV7grNKACz2yWcXLrpAG3SYej_SKWDTx8lHjDR5mjCm3s7OBNphGKhF52iaBz8H2o8NTpiPMbkVbYMfqHEJM4DGKYtN8h2OGPt4SQPG2aW4UaVXpJnYZTa9nYOf0Iw0prlZHZGd1riIx9_xkLzc3b7cPBRPz_ePN9dPhZUlpGIplGAAShlV8dbiktVYM7RVfoK2WjBjLDDFpTHLEivkuABsy1o2pa1KFIfkaoOd5uWAjc0TBOP0FPrBhJX2ptf_M2P_qjv_oWsAqITMgLNvQPDvc55Dv-WNjLllXZZK1SAVrFV8o7LBxxiw_f2BM702UG8M1NlAvTZQQ645_dvab8WPY-ILL36b0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2288674874</pqid></control><display><type>article</type><title>gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Moreno-Mendoza, Daniel ; Casamonti, Elena ; Paoli, Donatella ; Chianese, Chiara ; Riera-Escamilla, Antoni ; Giachini, Claudia ; Fino, Maria Grazia ; Cioppi, Francesca ; Lotti, Francesco ; Vinci, Serena ; Magini, Angela ; Ars, Elisabet ; Sanchez-Curbelo, Josvany ; Ruiz-Castane, Eduard ; Lenzi, Andrea ; Lombardo, Francesco ; Krausz, Csilla</creator><creatorcontrib>Moreno-Mendoza, Daniel ; Casamonti, Elena ; Paoli, Donatella ; Chianese, Chiara ; Riera-Escamilla, Antoni ; Giachini, Claudia ; Fino, Maria Grazia ; Cioppi, Francesca ; Lotti, Francesco ; Vinci, Serena ; Magini, Angela ; Ars, Elisabet ; Sanchez-Curbelo, Josvany ; Ruiz-Castane, Eduard ; Lenzi, Andrea ; Lombardo, Francesco ; Krausz, Csilla</creatorcontrib><description>The association between impaired spermatogenesis and TGCT has stimulated research on shared genetic factors. Y chromosome-linked partial AZFc deletions predispose to oligozoospermia and were also studied in TGCT patients with controversial results. In the largest study reporting the association between gr/gr deletion and TGCT, sperm parameters were unknown. Hence, it remains to be established whether this genetic defect truly represents a common genetic link between TGCT and impaired sperm production. Our aim was to explore the role of the following Y chromosome-linked factors in the predisposition to TGCT: (i) gr/gr deletion in subjects with known sperm parameters; (ii) other partial AZFc deletions and, for the first time, the role of partial AZFc duplications; (iii) DAZ gene dosage variation. 497 TGCT patients and 2030 controls from two Mediterranean populations with full semen/andrological characterization were analyzed through a series of molecular genetic techniques. Our most interesting finding concerns the gr/gr deletion and DAZ gene dosage variation (i.e., DAZ copy number is different from the reference sequence), both conferring TGCT susceptibility. In particular, the highest risk was observed when normozoospermic TGCT and normozoospermic controls were compared (OR = 3.7; 95% CI = 1.5-9.1; p = 0.006 for gr/gr deletion and OR = 1.8; 95% CI = 1.1-3.0; p = 0.013 for DAZ gene dosage alteration). We report in the largest European study population the predisposing effect of gr/gr deletion to TGCT as an independent risk factor from impaired spermatogenesis. Our finding implies regular tumour screening/follow-up in male family members of TGCT patients with gr/gr deletion and in infertile gr/gr deletion carriers.</description><identifier>ISSN: 1018-4813</identifier><identifier>EISSN: 1476-5438</identifier><identifier>DOI: 10.1038/s41431-019-0420-7</identifier><identifier>PMID: 31053779</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Case-Control Studies ; Chromosome Deletion ; Chromosomes, Human, Y ; Clonal deletion ; Copy number ; DAZ gene ; Europe ; Gene Deletion ; Gene Dosage ; Gene Duplication ; Gene Frequency ; Gene Rearrangement ; Genetic factors ; Genotype ; Haplotypes ; Humans ; Male ; Neoplasms, Germ Cell and Embryonal - diagnosis ; Neoplasms, Germ Cell and Embryonal - genetics ; Oligozoospermia ; Phenotype ; Population studies ; Risk factors ; Semen ; Sperm ; Spermatogenesis ; Spermatogenesis - genetics ; Testicular Neoplasms - diagnosis ; Testicular Neoplasms - genetics ; Tumors ; Y chromosomes</subject><ispartof>European journal of human genetics : EJHG, 2019-10, Vol.27 (10), p.1578-1588</ispartof><rights>European Society of Human Genetics 2019.</rights><rights>European Society of Human Genetics 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-b38307788a851fceb06e60ec57887f590aac70814aab2e5e1e97ef264d2c52e3</citedby><cites>FETCH-LOGICAL-c427t-b38307788a851fceb06e60ec57887f590aac70814aab2e5e1e97ef264d2c52e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777534/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777534/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31053779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moreno-Mendoza, Daniel</creatorcontrib><creatorcontrib>Casamonti, Elena</creatorcontrib><creatorcontrib>Paoli, Donatella</creatorcontrib><creatorcontrib>Chianese, Chiara</creatorcontrib><creatorcontrib>Riera-Escamilla, Antoni</creatorcontrib><creatorcontrib>Giachini, Claudia</creatorcontrib><creatorcontrib>Fino, Maria Grazia</creatorcontrib><creatorcontrib>Cioppi, Francesca</creatorcontrib><creatorcontrib>Lotti, Francesco</creatorcontrib><creatorcontrib>Vinci, Serena</creatorcontrib><creatorcontrib>Magini, Angela</creatorcontrib><creatorcontrib>Ars, Elisabet</creatorcontrib><creatorcontrib>Sanchez-Curbelo, Josvany</creatorcontrib><creatorcontrib>Ruiz-Castane, Eduard</creatorcontrib><creatorcontrib>Lenzi, Andrea</creatorcontrib><creatorcontrib>Lombardo, Francesco</creatorcontrib><creatorcontrib>Krausz, Csilla</creatorcontrib><title>gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study</title><title>European journal of human genetics : EJHG</title><addtitle>Eur J Hum Genet</addtitle><description>The association between impaired spermatogenesis and TGCT has stimulated research on shared genetic factors. Y chromosome-linked partial AZFc deletions predispose to oligozoospermia and were also studied in TGCT patients with controversial results. In the largest study reporting the association between gr/gr deletion and TGCT, sperm parameters were unknown. Hence, it remains to be established whether this genetic defect truly represents a common genetic link between TGCT and impaired sperm production. Our aim was to explore the role of the following Y chromosome-linked factors in the predisposition to TGCT: (i) gr/gr deletion in subjects with known sperm parameters; (ii) other partial AZFc deletions and, for the first time, the role of partial AZFc duplications; (iii) DAZ gene dosage variation. 497 TGCT patients and 2030 controls from two Mediterranean populations with full semen/andrological characterization were analyzed through a series of molecular genetic techniques. Our most interesting finding concerns the gr/gr deletion and DAZ gene dosage variation (i.e., DAZ copy number is different from the reference sequence), both conferring TGCT susceptibility. In particular, the highest risk was observed when normozoospermic TGCT and normozoospermic controls were compared (OR = 3.7; 95% CI = 1.5-9.1; p = 0.006 for gr/gr deletion and OR = 1.8; 95% CI = 1.1-3.0; p = 0.013 for DAZ gene dosage alteration). We report in the largest European study population the predisposing effect of gr/gr deletion to TGCT as an independent risk factor from impaired spermatogenesis. Our finding implies regular tumour screening/follow-up in male family members of TGCT patients with gr/gr deletion and in infertile gr/gr deletion carriers.</description><subject>Case-Control Studies</subject><subject>Chromosome Deletion</subject><subject>Chromosomes, Human, Y</subject><subject>Clonal deletion</subject><subject>Copy number</subject><subject>DAZ gene</subject><subject>Europe</subject><subject>Gene Deletion</subject><subject>Gene Dosage</subject><subject>Gene Duplication</subject><subject>Gene Frequency</subject><subject>Gene Rearrangement</subject><subject>Genetic factors</subject><subject>Genotype</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasms, Germ Cell and Embryonal - diagnosis</subject><subject>Neoplasms, Germ Cell and Embryonal - genetics</subject><subject>Oligozoospermia</subject><subject>Phenotype</subject><subject>Population studies</subject><subject>Risk factors</subject><subject>Semen</subject><subject>Sperm</subject><subject>Spermatogenesis</subject><subject>Spermatogenesis - genetics</subject><subject>Testicular Neoplasms - diagnosis</subject><subject>Testicular Neoplasms - genetics</subject><subject>Tumors</subject><subject>Y chromosomes</subject><issn>1018-4813</issn><issn>1476-5438</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpVkctKxTAQhoMo3h_AjQRcV5Mm7eS4EES8geDGfchJp7WSNjVJhfMQvrM5HBXdZELmny8z8xNywtk5Z0JdRMml4AXji4LJkhWwRfa5hLqopFDb-c64KqTiYo8cxPjGWE4C3yV7grNKACz2yWcXLrpAG3SYej_SKWDTx8lHjDR5mjCm3s7OBNphGKhF52iaBz8H2o8NTpiPMbkVbYMfqHEJM4DGKYtN8h2OGPt4SQPG2aW4UaVXpJnYZTa9nYOf0Iw0prlZHZGd1riIx9_xkLzc3b7cPBRPz_ePN9dPhZUlpGIplGAAShlV8dbiktVYM7RVfoK2WjBjLDDFpTHLEivkuABsy1o2pa1KFIfkaoOd5uWAjc0TBOP0FPrBhJX2ptf_M2P_qjv_oWsAqITMgLNvQPDvc55Dv-WNjLllXZZK1SAVrFV8o7LBxxiw_f2BM702UG8M1NlAvTZQQ645_dvab8WPY-ILL36b0A</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Moreno-Mendoza, Daniel</creator><creator>Casamonti, Elena</creator><creator>Paoli, Donatella</creator><creator>Chianese, Chiara</creator><creator>Riera-Escamilla, Antoni</creator><creator>Giachini, Claudia</creator><creator>Fino, Maria Grazia</creator><creator>Cioppi, Francesca</creator><creator>Lotti, Francesco</creator><creator>Vinci, Serena</creator><creator>Magini, Angela</creator><creator>Ars, Elisabet</creator><creator>Sanchez-Curbelo, Josvany</creator><creator>Ruiz-Castane, Eduard</creator><creator>Lenzi, Andrea</creator><creator>Lombardo, Francesco</creator><creator>Krausz, Csilla</creator><general>Nature Publishing Group</general><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20191001</creationdate><title>gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study</title><author>Moreno-Mendoza, Daniel ; Casamonti, Elena ; Paoli, Donatella ; Chianese, Chiara ; Riera-Escamilla, Antoni ; Giachini, Claudia ; Fino, Maria Grazia ; Cioppi, Francesca ; Lotti, Francesco ; Vinci, Serena ; Magini, Angela ; Ars, Elisabet ; Sanchez-Curbelo, Josvany ; Ruiz-Castane, Eduard ; Lenzi, Andrea ; Lombardo, Francesco ; Krausz, Csilla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-b38307788a851fceb06e60ec57887f590aac70814aab2e5e1e97ef264d2c52e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Case-Control Studies</topic><topic>Chromosome Deletion</topic><topic>Chromosomes, Human, Y</topic><topic>Clonal deletion</topic><topic>Copy number</topic><topic>DAZ gene</topic><topic>Europe</topic><topic>Gene Deletion</topic><topic>Gene Dosage</topic><topic>Gene Duplication</topic><topic>Gene Frequency</topic><topic>Gene Rearrangement</topic><topic>Genetic factors</topic><topic>Genotype</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasms, Germ Cell and Embryonal - diagnosis</topic><topic>Neoplasms, Germ Cell and Embryonal - genetics</topic><topic>Oligozoospermia</topic><topic>Phenotype</topic><topic>Population studies</topic><topic>Risk factors</topic><topic>Semen</topic><topic>Sperm</topic><topic>Spermatogenesis</topic><topic>Spermatogenesis - genetics</topic><topic>Testicular Neoplasms - diagnosis</topic><topic>Testicular Neoplasms - genetics</topic><topic>Tumors</topic><topic>Y chromosomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moreno-Mendoza, Daniel</creatorcontrib><creatorcontrib>Casamonti, Elena</creatorcontrib><creatorcontrib>Paoli, Donatella</creatorcontrib><creatorcontrib>Chianese, Chiara</creatorcontrib><creatorcontrib>Riera-Escamilla, Antoni</creatorcontrib><creatorcontrib>Giachini, Claudia</creatorcontrib><creatorcontrib>Fino, Maria Grazia</creatorcontrib><creatorcontrib>Cioppi, Francesca</creatorcontrib><creatorcontrib>Lotti, Francesco</creatorcontrib><creatorcontrib>Vinci, Serena</creatorcontrib><creatorcontrib>Magini, Angela</creatorcontrib><creatorcontrib>Ars, Elisabet</creatorcontrib><creatorcontrib>Sanchez-Curbelo, Josvany</creatorcontrib><creatorcontrib>Ruiz-Castane, Eduard</creatorcontrib><creatorcontrib>Lenzi, Andrea</creatorcontrib><creatorcontrib>Lombardo, Francesco</creatorcontrib><creatorcontrib>Krausz, Csilla</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of human genetics : EJHG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moreno-Mendoza, Daniel</au><au>Casamonti, Elena</au><au>Paoli, Donatella</au><au>Chianese, Chiara</au><au>Riera-Escamilla, Antoni</au><au>Giachini, Claudia</au><au>Fino, Maria Grazia</au><au>Cioppi, Francesca</au><au>Lotti, Francesco</au><au>Vinci, Serena</au><au>Magini, Angela</au><au>Ars, Elisabet</au><au>Sanchez-Curbelo, Josvany</au><au>Ruiz-Castane, Eduard</au><au>Lenzi, Andrea</au><au>Lombardo, Francesco</au><au>Krausz, Csilla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study</atitle><jtitle>European journal of human genetics : EJHG</jtitle><addtitle>Eur J Hum Genet</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>27</volume><issue>10</issue><spage>1578</spage><epage>1588</epage><pages>1578-1588</pages><issn>1018-4813</issn><eissn>1476-5438</eissn><abstract>The association between impaired spermatogenesis and TGCT has stimulated research on shared genetic factors. Y chromosome-linked partial AZFc deletions predispose to oligozoospermia and were also studied in TGCT patients with controversial results. In the largest study reporting the association between gr/gr deletion and TGCT, sperm parameters were unknown. Hence, it remains to be established whether this genetic defect truly represents a common genetic link between TGCT and impaired sperm production. Our aim was to explore the role of the following Y chromosome-linked factors in the predisposition to TGCT: (i) gr/gr deletion in subjects with known sperm parameters; (ii) other partial AZFc deletions and, for the first time, the role of partial AZFc duplications; (iii) DAZ gene dosage variation. 497 TGCT patients and 2030 controls from two Mediterranean populations with full semen/andrological characterization were analyzed through a series of molecular genetic techniques. Our most interesting finding concerns the gr/gr deletion and DAZ gene dosage variation (i.e., DAZ copy number is different from the reference sequence), both conferring TGCT susceptibility. In particular, the highest risk was observed when normozoospermic TGCT and normozoospermic controls were compared (OR = 3.7; 95% CI = 1.5-9.1; p = 0.006 for gr/gr deletion and OR = 1.8; 95% CI = 1.1-3.0; p = 0.013 for DAZ gene dosage alteration). We report in the largest European study population the predisposing effect of gr/gr deletion to TGCT as an independent risk factor from impaired spermatogenesis. Our finding implies regular tumour screening/follow-up in male family members of TGCT patients with gr/gr deletion and in infertile gr/gr deletion carriers.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>31053779</pmid><doi>10.1038/s41431-019-0420-7</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1018-4813 |
ispartof | European journal of human genetics : EJHG, 2019-10, Vol.27 (10), p.1578-1588 |
issn | 1018-4813 1476-5438 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6777534 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Case-Control Studies Chromosome Deletion Chromosomes, Human, Y Clonal deletion Copy number DAZ gene Europe Gene Deletion Gene Dosage Gene Duplication Gene Frequency Gene Rearrangement Genetic factors Genotype Haplotypes Humans Male Neoplasms, Germ Cell and Embryonal - diagnosis Neoplasms, Germ Cell and Embryonal - genetics Oligozoospermia Phenotype Population studies Risk factors Semen Sperm Spermatogenesis Spermatogenesis - genetics Testicular Neoplasms - diagnosis Testicular Neoplasms - genetics Tumors Y chromosomes |
title | gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A16%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=gr/gr%20deletion%20predisposes%20to%20testicular%20germ%20cell%20tumour%20independently%20from%20altered%20spermatogenesis:%20results%20from%20the%20largest%20European%20study&rft.jtitle=European%20journal%20of%20human%20genetics%20:%20EJHG&rft.au=Moreno-Mendoza,%20Daniel&rft.date=2019-10-01&rft.volume=27&rft.issue=10&rft.spage=1578&rft.epage=1588&rft.pages=1578-1588&rft.issn=1018-4813&rft.eissn=1476-5438&rft_id=info:doi/10.1038/s41431-019-0420-7&rft_dat=%3Cproquest_pubme%3E2288674874%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2288674874&rft_id=info:pmid/31053779&rfr_iscdi=true |